272 related articles for article (PubMed ID: 23881723)
1. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.
Madsen BS; Havelund T; Krag A
Adv Ther; 2013 Jul; 30(7):659-70. PubMed ID: 23881723
[TBL] [Abstract][Full Text] [Related]
2. [Managing the complications of cirrhosis].
Deltenre P; Mathurin P; Barraud H; Bronowicki JP; Jacquet E; Puche P; Jaber S; Navarro F; Pageaux GP
Rev Prat; 2005 Sep; 55(14):1555-63. PubMed ID: 16255297
[TBL] [Abstract][Full Text] [Related]
3. Could antioxidants be the "magic pill" for cirrhosis-related complications? A pathophysiological appraisal.
Assimakopoulos SF; Gogos C; Labropoulou-Karatza C
Med Hypotheses; 2011 Sep; 77(3):419-23. PubMed ID: 21703771
[TBL] [Abstract][Full Text] [Related]
4. Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?
Thiele M; Wiest R; Gluud LL; Albillos A; Krag A
Med Hypotheses; 2013 Nov; 81(5):871-4. PubMed ID: 24060485
[TBL] [Abstract][Full Text] [Related]
5. Current and future pharmacological therapies for managing cirrhosis and its complications.
Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
[TBL] [Abstract][Full Text] [Related]
6. Management of patients with complications of cirrhosis.
Fowler C
Nurse Pract; 2013 Apr; 38(4):14-21; quiz 22-3. PubMed ID: 23454902
[TBL] [Abstract][Full Text] [Related]
7. Outpatient management of cirrhosis: a narrative review.
Mathews RE; McGuire BM; Estrada CA
South Med J; 2006 Jun; 99(6):600-6. PubMed ID: 16800415
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.
Vlachogiannakos J; Viazis N; Vasianopoulou P; Vafiadis I; Karamanolis DG; Ladas SD
J Gastroenterol Hepatol; 2013 Mar; 28(3):450-5. PubMed ID: 23216382
[TBL] [Abstract][Full Text] [Related]
9. The Use of Rifaximin in Patients With Cirrhosis.
Caraceni P; Vargas V; Solà E; Alessandria C; de Wit K; Trebicka J; Angeli P; Mookerjee RP; Durand F; Pose E; Krag A; Bajaj JS; Beuers U; Ginès P;
Hepatology; 2021 Sep; 74(3):1660-1673. PubMed ID: 33421158
[TBL] [Abstract][Full Text] [Related]
10. Complications of cirrhosis.
Dong MH; Saab S
Dis Mon; 2008 Jul; 54(7):445-56. PubMed ID: 18570914
[No Abstract] [Full Text] [Related]
11. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
12. [Complications of liver cirrhosis].
Appenrodt B; Trebicka J; Sauerbruch T
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1601-4. PubMed ID: 21809252
[No Abstract] [Full Text] [Related]
13. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?
Burza MA; Marschall HU; Napoleone L; Molinaro A
Pharmacol Res; 2017 May; 119():20-26. PubMed ID: 28099882
[TBL] [Abstract][Full Text] [Related]
14. Portal hypertension.
Garcia-Tsao G
Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota-related complications in cirrhosis.
Gómez-Hurtado I; Such J; Sanz Y; Francés R
World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
[TBL] [Abstract][Full Text] [Related]
16. Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials.
Thiele M; Albillos A; Abazi R; Wiest R; Gluud LL; Krag A
Liver Int; 2015 Aug; 35(8):2009-16. PubMed ID: 25581713
[TBL] [Abstract][Full Text] [Related]
17. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
[TBL] [Abstract][Full Text] [Related]
18. β blockers in liver cirrhosis.
Triantos C; Thomopoulos K; Lampropoulou-Karatza C
Gastroenterology; 2014 Oct; 147(4):941. PubMed ID: 25171876
[No Abstract] [Full Text] [Related]
19. Rolling review: the treatment of major complications of cirrhosis.
Bosch J; Bruix J; Mas A; Navasa M; Rodés J
Aliment Pharmacol Ther; 1994 Dec; 8(6):639-57. PubMed ID: 7696453
[No Abstract] [Full Text] [Related]
20. NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: "THE THERAPEUTIC WINDOW".
Dimache M; Gîrleanu I; Carpov E; Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):23-8. PubMed ID: 27125068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
